Covid-19: Trials for inhaled version of remdesivir to start in August

Covid-19: Trials for inhaled version of remdesivir to start in August

Gilead Sciences has said it will soon start clinical trials for inhaled formulation of its antiviral drug remdesivir used for the treatment of Covid-19. The US drugmaker said the trials will begin in…
Read More

Leave a Reply